Humans

1.
Thomas Hartung. ToxAIcology - The evolving role of artificial intelligence in advancing toxicology and modernizing regulatory science. ALTEX. 2023;40(4):559-570. doi:10.14573/altex.2309191
View Full Reference
1.
Katerina Trajanoska, Claude Bhérer, Daniel Taliun, Sirui Zhou, J. Brent Richards, Vincent Mooser. From target discovery to clinical drug development with human genetics. Nature. 2023;620(7975):737-745. doi:10.1038/s41586-023-06388-8
View Full Reference
1.
Michael Eisenstein. Organoids open fresh paths to biomedical advances. Nature. 2022;612(7940):S34-S35. doi:10.1038/d41586-022-04214-1
View Full Reference
1.
Tingting Tao, Pengwei Deng, Yaqing Wang, et al. Microengineered Multi-Organoid System from hiPSCs to Recapitulate Human Liver-Islet Axis in Normal and Type 2 Diabetes. Advanced Science (Weinheim, Baden-Wurttemberg, Germany). 2022;9(5):e2103495. doi:10.1002/advs.202103495
View Full Reference
1.
Sebastian Hoffmann, Paul Whaley, Katya Tsaioun. How evidence-based methodologies can help identify and reduce uncertainty in chemical risk assessment. ALTEX. 2022;39(2):175-182. doi:10.14573/altex.2201131
View Full Reference
1.
Paul Whaley, Thomas Piggott, Rebecca L. Morgan, et al. Biological plausibility in environmental health systematic reviews: a GRADE concept paper. Journal of Clinical Epidemiology. 2022;146:32-46. doi:10.1016/j.jclinepi.2022.02.011
View Full Reference
1.
Shengli Ding, Carolyn Hsu, Zhaohui Wang, et al. Patient-derived micro-organospheres enable clinical precision oncology. Cell Stem Cell. 2022;29(6):905-917.e6. doi:10.1016/j.stem.2022.04.006
View Full Reference
1.
Daniel Krewski, Patrick Saunders-Hastings, Robert A. Baan, et al. Development of an Evidence-Based Risk Assessment Framework. ALTEX. 2022;39(4):667-693. doi:10.14573/altex.2004041
View Full Reference
1.
Ivan Rusyn, Courtney Sakolish, Yuki Kato, et al. Microphysiological Systems Evaluation: Experience of TEX-VAL Tissue Chip Testing Consortium. Toxicological Sciences: An Official Journal of the Society of Toxicology. 2022;188(2):143-152. doi:10.1093/toxsci/kfac061
View Full Reference
1.
Manuela Cassotta, Hugo Geerts, Lise Harbom, et al. The future of Parkinson’s disease research: A new paradigm of human-specific investigation is necessary… and possible. ALTEX. 2022;39(4):694-709. doi:10.14573/altex.2203161
View Full Reference